Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
68.63
-3.27 (-4.55%)
At close: Apr 28, 2026, 4:00 PM EDT
68.63
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $5.92 billion as of April 28, 2026. Its market cap has increased by 723.25% in one year.
Market Cap
5.92B
Enterprise Value
5.23B
1-Year Change
723.25%
Ranking
Category
Stock Price
$68.63
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $5.92B, an increase of 5,199.89%. That is a compound annual growth rate of 48.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 5.65B | 122.16% |
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 6.38B |
| Belite Bio | 6.34B |
| Apogee Therapeutics | 6.32B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Cogent Biosciences | 5.93B |
| Rhythm Pharmaceuticals | 5.85B |
| Celcuity | 5.85B |